Before Submission
Authors should submit only original work that has not been published previously and is not under consideration elsewhere, except where legitimate preprint or conference-disclosure policies are explicitly stated. All authors must approve the final manuscript, agree to its submission, and accept responsibility for the integrity of their contributions. The corresponding author coordinates communication with the journal and ensures that required declarations are complete.
Authorship and Contributions
Authorship should follow the four ICMJE criteria: substantial contribution to the work; drafting or critical revision; final approval; and accountability for all aspects of the work. Contributors who do not meet all criteria should be acknowledged with permission. Authors should provide a contribution statement, ideally using CRediT roles. Changes to the author list after submission require a written explanation and agreement from all affected authors.
Manuscript Preparation
Prepare a clear English-language manuscript in an editable Word format. Include a concise title, author names, affiliations, corresponding-author contact details, abstract where applicable, keywords, main text, declarations, references, and numbered tables and figures. Use consistent terminology, SI units, generic drug names, and a clear distinction between results and interpretation. A separate title page and anonymized main document may be requested to support double-anonymous review.
Recommended Structure
Original research should ordinarily contain Introduction, Materials and Methods, Results, Discussion, and Conclusion. Systematic reviews should describe the research question, eligibility criteria, information sources, search strategy, selection, data extraction, risk-of-bias assessment, and synthesis methods. Narrative reviews should identify their scope and literature-selection approach without misrepresenting the work as a systematic review. Case reports should include patient consent and follow CARE guidance. Letters should present a focused, evidence-supported argument.
Abstracts and Keywords
Original research abstracts should normally be structured under Objective/Aim, Methods, Results, and Conclusion. Reviews and case reports may use an appropriate format for the article type. Provide three to six descriptive keywords, preferably using MeSH terms where relevant. Abstracts should accurately reflect the manuscript and should not contain unsupported conclusions.
References and Citations
Use the Vancouver numbered reference style. Number references in the order of first citation and cite them consistently in the text. Include complete bibliographic details and DOI links when available. Authors are responsible for verifying each reference against the original source. Do not cite fabricated, withdrawn, or irrelevant literature. Any reliance on retracted work must be explicitly justified.
Tables, Figures, and Supplementary Files
Number tables and figures in order of appearance and refer to each in the text. Supply informative captions, define abbreviations, and identify statistical tests and denominators. Tables must be editable; figures should be of publication quality. Obtain permission for copyrighted material and remove patient identifiers unless disclosure is justified and consented to. Supplementary materials must be clearly labeled and scientifically relevant.
Research Ethics and Consent
Provide the name of the ethics committee or institutional review board, approval date, and reference number when applicable, or a clear explanation of exemption or non-requirement. State how informed consent was obtained or waived. For identifiable case information or images, obtain explicit consent for publication. Animal studies must describe welfare oversight and relevant standards. Ethical approval must never be invented or backdated.
Registration and Data Transparency
Prospective registration is expected for clinical trials according to ICMJE standards. Include the registry name, identifier, and registration date. Authors should disclose study protocols and preregistration where relevant, provide a data availability statement, and explain legitimate privacy, legal, or contractual restrictions. Statistical methods, sample-size decisions, missing-data handling, and software versions should be sufficiently transparent for appraisal.
Funding, Conflicts, and AI Use
Disclose all sources of financial and material support and the role of funders. Each author must declare relevant financial and non-financial competing interests, including an explicit “none declared” statement when appropriate. Generative AI tools cannot qualify as authors. Any material use of AI-assisted tools in drafting, analysis, or image production should be disclosed, and authors remain responsible for accuracy, originality, confidentiality, and attribution.
Submission and Editorial Screening
Submit through the journal’s manuscript submission portal accessible from www.multidisipmed.com. The editorial office checks scope, formatting, completeness, ethical declarations, and similarity concerns before peer review. Manuscripts may be returned for technical correction or rejected at screening. Submission does not guarantee review or acceptance.
Revision and Proofs
Revised submissions should include a point-by-point response to each reviewer and a clearly marked revised manuscript. Authors must address methodological concerns substantively, not merely cosmetically. The corresponding author should review page proofs carefully and return corrections within the stated deadline. Substantive post-acceptance changes may require renewed editorial evaluation.
Fees and Licensing
Any article processing charge, waiver, refund policy, copyright terms, and Creative Commons license must be published prominently before authors commit to publication. Until these are formally adopted, authors should contact the editorial office for confirmation. No fee should be represented as mandatory unless an approved fee schedule is publicly available.
Relevant International Guidance